Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02188368
Title Pomalidomide for Lenalidomide for Failures
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Oncotherapeutics
Indications

multiple myeloma

Therapies

Bortezomib + Carfilzomib + Clarithromycin

Pegylated liposomal-doxorubicin + Pomalidomide

Pomalidomide

Age Groups:
Covered Countries USA


No variant requirements are available.